贫困与儿童急性淋巴细胞白血病复发风险:儿童肿瘤协作组AALL03N1研究报告
该研究为COG-AALL03N1的二次分析,利用美国人口普查局数据按联邦贫困阈值将592例接受维持治疗的ALL患儿分为极端贫困与非极端贫困组。中位随访7.9年,极端贫困组3年累积复发率14.3%显著高于非极端贫困组7.6%,多变量分析显示极端贫困患儿复发风险为对照的1.95倍。
要点
- 极端贫困患儿3年累积复发率为14.3%,高于非极端贫困患儿的7.6%。
- 多变量分析显示极端贫困患儿复发风险为对照的1.95倍,纳入种族/民族后关联减弱。
- 极端贫困组巯嘌呤不依从比例更高(57.1% vs 40.9%),但不依从不能完全解释贫困与复发的关联。
核心结论
- 极端贫困与ALL维持治疗患儿复发风险升高相关,该关联在纳入种族/民族后减弱,可能因共线性。
- 不依从不能完全解释贫困与复发风险的关联。
- 未来研究需理解极端贫困与复发风险关联的机制。
研究设计与样本
- COG-AALL03N1的二次分析,纳入592例接受ALL维持治疗的患儿。
- 利用美国人口普查局数据,按自报年家庭收入与家庭人数计算年度联邦贫困阈值。
- 联邦贫困阈值高于年家庭收入120%者定义为极端贫困。
- 采用多变量比例亚分布风险回归估计复发风险。
- 试验注册号NCT00268528。
主要发现
- 592例中12.3%的患儿处于极端贫困。
- 中位随访7.9年,自研究入组起3年累积复发率在极端贫困组为14.3%,非极端贫困组为7.6%。
- 多变量分析显示极端贫困患儿复发风险为对照的1.95倍。
- 纳入种族/民族后该关联减弱,可能因种族/民族与贫困存在共线性。
- 极端贫困组巯嘌呤不依从比例为57.1%,非极端贫困组为40.9%。
局限性
- 未来研究需理解极端贫困与复发风险关联的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The association between individual-level poverty and relapse in children receiving maintenance treatment for acute lymphoblastic leukemia (ALL) remains unclear. In a secondary analysis of COG-AALL03N1, we used data from US Census Bureau to categorize patients living below year-specific federal poverty thresholds, calculated using self-reported annual household income and size of household. Participants with federal poverty thresholds above 120% of their yearly household income were categorized as living in extreme poverty. Hazard of relapse was estimated using multivariable proportional subdistributional hazards regression for patients living in extreme poverty while receiving ALL maintenance therapy after adjusting for relevant predictors. Among 592 patients in this analysis, 12.3% of the patients were living in extreme poverty. After a median follow-up of 7.9 years, the cumulative incidence of relapse at 3 years from study enrollment among those living in extreme poverty was significantly higher (14.3%) than those not living in extreme poverty (7.6%). Multivariable analysis demonstrated that children living in extreme poverty had a 1.95-fold greater hazard of relapse than those not living in extreme poverty; this association was mitigated after the inclusion of race/ethnicity in the model, likely because of collinearity between race/ethnicity and poverty. A greater proportion of children living in extreme poverty were nonadherent to mercaptopurine (57.1% vs 40.9%); however, poor adherence did not completely explain the association between poverty and relapse risk. Future studies need to understand the mechanisms underlying the association between extreme poverty and relapse risk. This trial was registered at www.clinicaltrials.gov as #NCT00268528.
引用
- Wadhwa A, Chen Y, Hageman L, et al. Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report. Blood. 2023. PMID: 37070673. doi:10.1182/blood.2023019631
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。